KRMD
Income statement / Annual
Last year (2023), KORU Medical Systems, Inc.'s total revenue was $28.52 M,
an increase of 2.23% from the previous year.
In 2023, KORU Medical Systems, Inc.'s net income was -$13.74 M.
See KORU Medical Systems, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
02/28/2017 |
02/29/2016 |
02/28/2015 |
Operating Revenue |
$28.52 M
|
$27.90 M
|
$23.49 M
|
$24.18 M
|
$23.16 M
|
$17.35 M
|
$15.98 M
|
$12.29 M
|
$12.25 M
|
$11.24 M
|
Cost of Revenue |
$11.81 M |
$12.53 M |
$9.72 M |
$9.24 M |
$8.31 M |
$6.54 M |
$6.52 M |
$4.72 M |
$4.64 M |
$4.56 M |
Gross Profit |
$16.71 M |
$15.37 M |
$13.77 M |
$14.94 M |
$14.85 M |
$10.81 M |
$9.46 M |
$7.57 M |
$7.60 M |
$6.69 M |
Gross Profit Ratio |
0.59 |
0.55 |
0.59 |
0.62 |
0.64 |
0.62 |
0.59 |
0.62 |
0.62 |
0.59 |
Research and Development
Expenses |
$5.74 M
|
$4.96 M
|
$2.47 M
|
$1.30 M
|
$740,475.00
|
$241,124.00
|
$60,704.00
|
$237,486.00
|
$207,282.00
|
$468,154.00
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$20.37 M
|
$20.61 M
|
$17.86 M
|
$12.03 M
|
$9.77 M
|
$8.20 M
|
$7.91 M
|
$7.77 M
|
$5.94 M
|
$4.79 M
|
Other Expenses |
$870,390.00 |
$0.00 |
$679,907.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$9,198.00 |
$0.00 |
Operating Expenses |
$26.11 M |
$26.15 M |
$20.80 M |
$13.74 M |
$10.85 M |
$8.75 M |
$7.97 M |
$8.31 M |
$6.42 M |
$5.54 M |
Cost And Expenses |
$38.79 M |
$38.68 M |
$30.52 M |
$22.98 M |
$19.16 M |
$15.29 M |
$14.49 M |
$13.03 M |
$11.07 M |
$10.10 M |
Interest Income |
$561,328.00 |
$145,587.00 |
$13,083.00 |
$42,395.00 |
$80,663.00 |
$28,104.00 |
$0.00 |
$2,937.00 |
$0.00 |
$5,623.00 |
Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$1,886.00 |
$3,412.00 |
$512.00 |
Depreciation &
Amortization |
$870,390.00
|
$587,137.00
|
$463,130.00
|
$418,595.00
|
$340,229.00
|
$309,263.00
|
$308,708.00
|
$300,611.00
|
$271,566.00
|
$283,875.00
|
EBITDA |
-$9.40 M
|
-$10.19 M
|
-$6.57 M
|
$1.61 M
|
$4.34 M
|
$2.37 M
|
$1.88 M
|
-$474,202.00
|
$1.42 M
|
$1.36 M
|
EBITDA Ratio |
-0.33 |
-0.36 |
-0.28 |
0.17 |
0.33 |
0.19 |
0.11 |
-0.04 |
0.12 |
0.13 |
Operating Income Ratio
|
-0.36
|
-0.39
|
-0.3
|
-0.05
|
0.03
|
0.07
|
0.09
|
-0.06
|
0.1
|
0.1
|
Total Other
Income/Expenses Net |
$496,397.00
|
$105,713.00
|
$665,094.00
|
$60,522.00
|
$110,739.00
|
$12,414.00
|
$85,183.00
|
-$40,448.00
|
-$38,814.00
|
-$72,855.00
|
Income Before Tax |
-$9.77 M |
-$10.68 M |
-$6.36 M |
-$1.19 M |
$696,418.00 |
$1.18 M |
$1.57 M |
-$776,699.00 |
$1.14 M |
$1.07 M |
Income Before Tax Ratio
|
-0.34
|
-0.38
|
-0.27
|
-0.05
|
0.03
|
0.07
|
0.1
|
-0.06
|
0.09
|
0.1
|
Income Tax Expense |
$3.97 M |
-$2.01 M |
-$1.80 M |
$17,800.00 |
$132,069.00 |
$266,380.00 |
$483,075.00 |
-$241,700.00 |
$359,706.00 |
$321,419.00 |
Net Income |
-$13.74 M |
-$8.66 M |
-$4.56 M |
-$1.21 M |
$564,349.00 |
$910,570.00 |
$1.09 M |
-$534,999.00 |
$782,864.00 |
$753,117.00 |
Net Income Ratio |
-0.48 |
-0.31 |
-0.19 |
-0.05 |
0.02 |
0.05 |
0.07 |
-0.04 |
0.06 |
0.07 |
EPS |
-0.3 |
-0.19 |
-0.1 |
-0.0289 |
0.0146 |
0.0239 |
0.0287 |
-0.0141 |
0.02 |
0.02 |
EPS Diluted |
-0.3 |
-0.19 |
-0.1 |
-0.0289 |
0.0144 |
0.0234 |
0.0283 |
-0.0141 |
0.02 |
0.02 |
Weighted Average Shares
Out |
$45.60 M
|
$45.00 M
|
$44.39 M
|
$41.93 M
|
$38.78 M
|
$38.13 M
|
$37.87 M
|
$37.83 M
|
$37.99 M
|
$37.63 M
|
Weighted Average Shares
Out Diluted |
$45.60 M
|
$45.00 M
|
$44.39 M
|
$41.93 M
|
$39.06 M
|
$38.92 M
|
$38.39 M
|
$37.88 M
|
$37.99 M
|
$37.63 M
|
Link |
|
|
|
|
|
|
|
|
|
|